ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Hypertension"

  • 2021 American Transplant Congress

    Recipient and Kidney Allograft Outcomes from Hypertensive Live-Donor in the United States

    S. Riad1, S. Jackson2, D. Vock3, A. Matas4

    1Medicine, University of Minnesota, Minneapolis, MN, 2Complex Care Analytics, M-Health Fairview, Minneapolis, MN, 3School of Public Health, University of Minnesota, Minneapolis, MN, 4Surgery, University of Minnesota, Minneapolis, MN

    *Purpose: Controlled hypertension in select prospective kidney donors is no longer an exclusion criterion for donation. We examined the association between pre-donation hypertension (HTN) and…
  • 2021 American Transplant Congress

    Portal Hypertension Abrogates Trail Expression of Liver Resident Nk Cells via Il-33

    Y. Imaoka, M. Ohira, K. Sato, H. Ohdan

    Hiroshima Uni., Hiroshima, Japan

    *Purpose: Portal vein hypertension (PHT) is associated with poor prognosis, risk factors for small graft syndrome, bloodstream infection, and acute rejection after living donor liver…
  • 2021 American Transplant Congress

    Native Nephrectomy in Pediatric Kidney Transplant Recipients

    D. Yoeli1, A. Sater1, A. Peace1, M. E. Wachs1, M. Bock2, M. A. Adams1

    1Transplant Surgery, Children’s Hospital Colorado, Aurora, CO, 2Pediatric Nephrology, Children’s Hospital Colorado, Aurora, CO

    *Purpose: Data on native nephrectomy in children with renal disease requiring kidney transplantation is scarce. The aim of this study was to characterize demographics and…
  • 2020 American Transplant Congress

    Long-Term Outcomes in Recipients of Allografts from Living Kidney Donors with Hypertension

    F. Al Ammary1, S. Yu2, A. Muzaale2, L. Luckmini2, D. C. Crews1, D. Brennan1, D. Segev2, A. B. Massie2

    1Medicine, Johns Hopkins, Baltimore, MD, 2Surgery, Johns Hopkins, Baltimore, MD

    *Purpose: Allografts from living kidney donors may “carry” subclinical pathological abnormalities to the recipient and thus lead to adverse clinical outcomes. Because one mechanism underlying…
  • 2020 American Transplant Congress

    Minor Negative Effects of Calcineurin Inhibitor Based Immunosuppression on Pregnancy Outcomes after Renal Transplantation in the Netherlands

    L. M. Koenjer1, J. R. Meinderts2, A. T. Lely3, M. F. de Jong2, O. W. van der Heijden1, R. G. van der Molen4, H. W. van Hamersvelt5

    1Obstetrics and Gynaecology, Radboud University Medical Centre, Nijmegen, Netherlands, 2Nephrology, University Medical Center Groningen, Groningen, Netherlands, 3Obstetrics and Gynaecology, University Medical Center Utrecht, Utrecht, Netherlands, 4Immunology, Radboud University Medical Centre, Nijmegen, Netherlands, 5Nephrology, Radboud University Medical Centre, Nijmegen, Netherlands

    *Purpose: Pregnancies after renal transplantation became more frequent over the past years, also in patients with compromised renal function. Immunosuppression may influence pregnancy outcome. It…
  • 2020 American Transplant Congress

    Impact on Graft Histology of Steroid Withdrawal versus Standard Immunosuppression: Randomized, Parallel Group, Controlled Clinical Trial in Low Immunological Risk Kidney Transplant Patients

    E. Gutiérrez Vílchez1, T. Vázquez1, V. López1, M. León2, E. Sola1, J. Sellares3, M. Cobo4, J. Cruzado5, A. Torío6, J. Kanter7, P. Ruiz-Esteban1, D. Hernández1

    1Nephrology Service, Regional University Hospital, University of Malaga, IBIMA, REDinREN (RD16/0009/0006), Málaga, Spain, 2Pathology Department, Regional University Hospital, University of Malaga, IBIMA, REDinREN (RD16/0009/0006), Málaga, Spain, 3Nephrology Department, Hospital Vall de Hebron, Barcelona, Spain, 4Cardiology Department, Hospital Marqués de Valdecilla, Santander, Spain, 5Nephrology Department, Hospital de Bellvitge, Barcelona, Spain, 6Immunology, Regional University Hospital, University of Malaga, IBIMA, REDinREN (RD16/0009/0006), Málaga, Spain, 7Nephrology Department, Hospital Universitario Dr. Peset, Valencia, Spain

    *Purpose: Steroid withdrawal can improve cardiovascular risk but little is known about its impact on graft histology and donor-specific antibodies.*Methods: 105 patients with a first…
  • 2020 American Transplant Congress

    CHAIR Score: A Novel Risk Stratification in Transplant Renal Artery Stenosis

    X. Tian, W. Duan, T. Yan, X. Wu

    Henan Province People's Hospital, Zhengzhou, Henan Province, China

    *Purpose: The aim of the study is to evaluate the clinical application of CHAIR score based on creatinine (C), hypertension (H), age (A), imaging evidence…
  • 2020 American Transplant Congress

    Predonation Hypertension and Early Postdonation Systolic Blood Pressure among Older Living Kidney Donors

    F. Al Ammary1, A. D. Muzaale2, D. C. Brennan1, D. L. Segev2, A. B. Massie2

    1Medicine, Johns Hopkins University, Baltimore, MD, 2Surgery, Johns Hopkins University, Baltimore, MD

    *Purpose: One mechanism underlying predonation hypertension in older (age≥50) living kidney donors is a reduced number of nephrons. The 50% nephron mass reduction associated with…
  • 2020 American Transplant Congress

    Kidney Transplant Recipient Outcomes from Older (60+) Hypertensive Living Donors

    A. Sharfuddin, T. Taber, O. Adebiyi, M. Panezai, D. Mishler, M. Yaqub

    Indiana University School of Medicine, Indianapolis, IN

    *Purpose: Although the data supporting long-term safety of nephrectomy in hypertensive donors has been reported, there is scarcity of long term data on the recipient…
  • 2020 American Transplant Congress

    Early Pancreas Allograft Failure is Associated with Donor Hypertension

    C. Masset1, J. Branchereau1, L. Badet2, C. Kerleau1, C. Legendre3, D. Glotz4, G. Karam1, D. Cantarovich1

    1University Hospital of Nantes, Nantes, France, 2University Hospital of Lyon, Lyon, France, 3Necker Hospital, Paris, France, 4Saint Louis Hospital, Paris, France

    *Purpose: About 10% of pancreas allografts are lost prematurely due to thrombosis. Despite identification of numerous risk factors, the incidence of early failure did not…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • …
  • 8
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences